GRAIL Inc. Company Profile
NASDAQ: GRALHealth CareMedical SpecialitiesUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Pre-market: 134.15 +1.16%
GRAIL at a glance
GRAIL Inc. (NASDAQ: GRAL) is a Medical Specialities company in the Health Care sector headquartered in Menlo Park, CA. GRAIL is led by Dr. Joshua J. Ofman M.D., M.S.H.S and employs about 910 people. At a market capitalization of $5.94 billion, it is considered a mid-cap company.
Its SEC Central Index Key (CIK) is 0001699031, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does GRAIL do?
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, its precision oncology portfolio consists of n RUO-targeted methylation-based platform that enables applications for disease prognostication, risk stratification, minimal residual disease detection, and recurrence and relapse monitoring. The company was incorporated in 2015 and is headquartered in Menlo Park, California.
Business description based on the company's public filings.
Company information
- Legal name
- GRAIL Inc.
- Ticker
- NASDAQ: GRAL
- Sector
- Health Care
- Industry
- Medical Specialities
- CEO
- Dr. Joshua J. Ofman M.D., M.S.H.S
- Employees
- 910
- Headquarters
- 1525 O’Brien Drive, Menlo Park, CA, United States
- Phone
- 833 694 2553
- Website
- grail.com
- Market cap
- $5.94B
- SEC CIK
- 0001699031
- Latest annual report
- 10-K · Mar 12, 2026
Companies similar to GRAIL
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| RDNTRadNet Inc. | 68.21 | -0.58% | $5.37B | vs GRAL |
| CONConcentra Group Holdings Parent Inc. | 36.61 | +0.58% | $4.67B | vs GRAL |
| BLLNBillionToOne Inc. Class A | 95.41 | -0.36% | $4.50B | vs GRAL |
| CAICaris Life Sciences Inc. | 27.50 | +1.48% | $7.77B | vs GRAL |
| VCYTVeracyte Inc. | 43.60 | +1.02% | $3.51B | vs GRAL |
| CELCCelcuity Inc. | 67.87 | +3.18% | $3.32B | vs GRAL |
| CDNACareDx Inc. | 62.21 | -1.32% | $3.22B | vs GRAL |
| ACHCAcadia Healthcare Company Inc. | 28.48 | -2.57% | $2.65B | vs GRAL |